MEDICAL DEVICE PROFILE
ORSIRO Sirolimus Eluting Coronary Stent System
Explore the manufacturer, product identifiers and associated FDA decisions for this device.
- Manufacturer / applicant
- Biotronik AG
- Product code
- NIQ
- Unique device identifier
- Not reported
- Indications for use
- Not reported
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
ORSIRO Sirolimus Eluting Coronary Stent SystemP170030/S066 | Biotronik AG | PMA supplement | Sep 24, 2026 | FDA |
ORSIRO Sirolimus Eluting Coronary Stent SystemP170030/S065 | Biotronik AG | PMA supplement | Aug 7, 2026 | FDA |
ORSIRO Sirolimus Eluting Coronary Stent SystemP170030/S062 | Biotronik AG | PMA supplement | Apr 15, 2026 | FDA |
| Biotronik AG | PMA approval | Feb 22, 2019 | FDA |
Source information
Retrieved Nov 20, 2026.



